Skip to main content

Table 3 Bivariable associations between taste, dose increased, supplements, pain, and dope sickness following a methadone formulation change

From: Patient perspectives of methadone formulation change in British Columbia, Canada: outcomes of a provincial survey

  Taste worsened Dose increased Began supplementing with opioids More dope sick
X2 Phi X2 Phi X2 Phi X2 Phi
Dose increased 9.93** 0.20**       
Began supplementing with opioids 3.99* 0.11* 21.50** 0.27**     
More dope sick 22.52** 0.25** 13.70** 0.20** 70.63** 0.46**   
More pain 22.23** 0.27** 13.06** 0.21** 29.43** 0.30** 77.28** 0.46**
  1. *p < 0.05, **p < 0.01
  2. degrees of freedom for Chi-square (X2) tests = 1